<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are clonal stem cell diseases of the bone marrow characterized by abnormalities in maturation of hematopoietic cells of <z:hpo ids='HP_0000001'>all</z:hpo> lineages </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients frequently have lower <z:chebi fb="23" ids="18059">lipids</z:chebi> and high rates of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and p53 (TP53) expression </plain></SENT>
<SENT sid="2" pm="."><plain>An association between the reduced <z:chebi fb="23" ids="18059">lipids</z:chebi> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and the expression of <z:chebi fb="23" ids="18059">lipid</z:chebi>-related genes was sought </plain></SENT>
<SENT sid="3" pm="."><plain>We further evaluated whether 3-hydroxy-3-<z:chebi fb="36" ids="29309">methyl</z:chebi>-<z:chebi fb="0" ids="15524">glutaryl-CoA</z:chebi> reductase (HMGcoAR) and <z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi> receptor (<z:chebi fb="15" ids="39026">LDL</z:chebi>-R) are regulated by TP53 in vivo and in vitro </plain></SENT>
<SENT sid="4" pm="."><plain>Gene expression was measured using real-time reverse transcription polymerase chain reaction on <z:chebi fb="40" ids="33697">RNA</z:chebi> extracted from bone marrow and peripheral blood from eight newly diagnosed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients and eight controls and from mice livers </plain></SENT>
<SENT sid="5" pm="."><plain>Serum <z:chebi fb="23" ids="18059">lipid</z:chebi> profile was measured using colorimetric enzymatic procedures </plain></SENT>
<SENT sid="6" pm="."><plain>Total- and <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> were lower in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients in comparison to controls (p = 0.04 and p = 0.01, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>HMGcoAR <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> increased in peripheral blood and bone marrow of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients compared to controls (p = 0.04 and p = 0.01, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="15" ids="39026">LDL</z:chebi>-R <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> was higher only in the peripheral blood of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients (p = 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>Comparable results were obtained in vivo </plain></SENT>
<SENT sid="10" pm="."><plain>The transcription of these genes correlates with TP53 activation as documented by p21 <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> elevation, a surrogate for TP53 activation and by using TP53 temperature-sensitive cells treated with adriamycin </plain></SENT>
<SENT sid="11" pm="."><plain>To conclude, an association between reduced <z:chebi fb="23" ids="18059">lipids</z:chebi> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and expression of HMGcoAR and <z:chebi fb="15" ids="39026">LDL</z:chebi>-R genes was documented </plain></SENT>
<SENT sid="12" pm="."><plain>The transcription of these genes can be regulated by TP53 </plain></SENT>
</text></document>